Cipher Pharmaceuticals Inc. (FRA:PHE)

Cipher Pharmaceuticals Revenue

Cipher Pharmaceuticals had revenue of $12.83M USD in the quarter ending September 30, 2025, with 23.75% growth. This brings the company's revenue in the last twelve months to $50.06M, up 89.17% year-over-year. In the year 2024, Cipher Pharmaceuticals had annual revenue of $33.36M with 57.66% growth.

• Revenue (ttm): $50.06M
• Revenue Growth: +89.17%
• P/S Ratio: 5.43
• Revenue / Employee: $10.01M
• Employees: 5
• Market Cap: 231.79M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	33.36M	12.20M	57.66%
Dec 31, 2023	21.16M	487.00K	2.36%
Dec 31, 2022	20.68M	-1.27M	-5.78%
Dec 31, 2021	21.94M	336.00K	1.56%
Dec 31, 2020	21.61M	-844.00K	-3.76%
Dec 31, 2019	22.45M	-298.00K	-1.31%
Dec 31, 2018	22.75M	-17.39M	-43.33%
Dec 31, 2017	40.14M	10.49M	35.38%
Dec 31, 2016	29.65M	-4.76M	-13.83%
Dec 31, 2015	34.41M	5.19M	17.74%
Dec 31, 2014	29.22M	3.83M	15.08%
Dec 31, 2013	25.39M	-	-